Skip to main content

Accelerated Cell Membrane Degradation in Alzheimer’s Disease Brain: Relationship to Amyloid Formation?

  • Conference paper
Phospholipids and Signal Transmission

Part of the book series: Nato ASI Series ((volume 70))

  • 69 Accesses

Abstract

Alzheimer’s disease is a degenerative brain disease first described by the German psychiatrist Alois Alzheimer (Alzheimer, 1907). His initial report was based upon the histological examination of brain tissue from a 51 year old female patient who experienced a rapid progressive deterioration of memory and died four and a half years after the onset of the first symptoms with total loss of mental functions. The brain of this woman showed generalized atrophy without macroscopic lesions. Using a novel silver staining method developed by Bielschowsky, Alzheimer found that more than a quarter of the cortical neurons contained fibrillary tangles, and that this abnormality was accompanied by the extracellular deposition of “multiple miliary lesions”, containing a “unique substance” which was later recognized to be amyloid. In his initial report, Alzheimer also described severe loss of nerve cells, which was most prominent in the upper layers of the brain cortex. More recently, Terry and colleagues used computerized image processing to confirm the loss of cortical neurons, and showed that large cortical neurons are particularly affected (Terry et al., 1981). Neuronal atrophy and the presence of degenerating neurites in the immediate vicinity of amyloid plaques has generated two controversial hypotheses: First, that amyloid is toxic to neurons, and, second, that amyloid is a byproduct of neuronal atrophy formed by neurons during their degeneration.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Anderson JP, Esch FS, Keim PS, Sambamurti K, Lieberburg I and Robakis NK (1991) Exact cleavage site of Alzheimer amyloid precursor in neuronal PC-12 cells. Neurosci Lett 128:126–128

    Article  PubMed  CAS  Google Scholar 

  • Alzheimer A (1907) Ueber eine eigenartige Erkrankung der Hirnrinde. Allg Z Psych & Psych-Gerichtl Med 64:146–148.

    Google Scholar 

  • Berridge MJ and Irvine RF (1989) Inositol phosphates and cell signalling. Nature 341:197–204

    Article  PubMed  CAS  Google Scholar 

  • Barany M, Chang Y-C and Arus C (1985) Increased glycerol-3-phosphoryl-choline in post-mortem Alzheimer’s brain. Lancet i:517

    Article  Google Scholar 

  • Baskin F, Rosenberg RN and Greenberg BD (1991) Increased release of an amyloidogenic C-terminal Alzheimer amyloid precursor protein fragment from stressed PC-12 cells. J Neurosci Res 29:127–132

    Article  PubMed  CAS  Google Scholar 

  • Blusztajn JK, Lopez Gonzalez-Coviella I, Logue M, Growdon JH and Wurtman RJ (1990) Levels of phospholipid catabolic intermediates, glycerophosphocholine and glycerophosphoethanolamine, are elevated in brains of Alzheimer’s disease but not of Down’s syndrome patients. Brain Res 536:240–244

    Article  PubMed  CAS  Google Scholar 

  • Blusztajn JK and Wurtman RJ (1983) Choline and cholinergic neurons. Science 221:614–620

    Article  PubMed  CAS  Google Scholar 

  • Buxbaum JD, Gandy SE, Cicchetti P, Ehrlich ME, Czernik AJ, Fracasso RP, Ramabhadran TV, Unterbeck AJ and Greengard P (1990) Processing of Alzheimer beta/A4 amyloid precursor protein: Modulation by agents that regulate protein phosphorylation. Proc Natl Acad Sci USA 87:6003–6006

    Article  PubMed  CAS  Google Scholar 

  • Cole G, Dobkins KR, Hansen LA, Terry RD and Saitoh T (1988) Decreased levels of protein kinase C in Alzheimer brain. Brain Res 452:165–174

    Article  PubMed  CAS  Google Scholar 

  • Dyrks T, Weidemann A, Multhaup G, Salbaum JM, Lemaire H-G, Kang L, Mueller-Hill B, Masters CL and Beyreuther K (1988) Identification, transmembrane orientation and biogenesis of the amyloid A4 precursor of Alzheimer’s disease. EMB0 J 7:949–957

    CAS  Google Scholar 

  • Esch FS, Keim PS, Beattie EC, Blacher RW, Culwell AR, Oltersdorf T, McClure D and Ward P (1990) Cleavage of amyloid beta peptide during constitutive processing of its precursor. Science 248:1122–1124

    Article  PubMed  CAS  Google Scholar 

  • Estus S, Golde TE, Kunishita T, Blades D, Lowery D, Eisen M, Usiak M, Qu X, Tabira T, Greenberg BD and Younkin SG (1992) Potentially amyloidogenic, carboxyl-terminal derivatives of the amyloid protein precursor. Science 255:726–728.

    Article  PubMed  CAS  Google Scholar 

  • Exton JH (1990) Signaling through phosphatidylcholine breakdown. J Biol Chem 265:1–4

    PubMed  CAS  Google Scholar 

  • Farooqui AA, Liss L and Horrocks L (1988) Stimulation of lipolytic enzymes in Alzheimer’s disease. Ann Neurol 23:306–308

    Article  PubMed  CAS  Google Scholar 

  • Glenner GG and Wong CW (1984) Alzheimer’s disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120:885–890

    Article  PubMed  CAS  Google Scholar 

  • Gandy S, Czernik AJ and Greengard P (1988) Phosphorylation of Alzheimer’s disease amyloid precursor peptide by protein kinase C and Ca2+/ calmodulin-dependent protein kinase II. Proc Natl Acad Sci USA 85:6218–6221

    Article  PubMed  CAS  Google Scholar 

  • Goate A, Chartier-Harlin M-C, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L, Mant R, Newton P, Rooke K, Roques P, Talbot C, Pericak-Vance M, Roses A, Williamson R, Rossor M, Owen M and Hardy J (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease. Nature 349:704–706

    Article  PubMed  CAS  Google Scholar 

  • Golde TE, Estus S, Younkin LH, Selkoe DJ and Younkin SG (1992) Processing of the amyloid protein precursor to potentially amyloidogenic derivatives. Science 255:728–730.

    Article  PubMed  CAS  Google Scholar 

  • Goldgaber D, Lerman M, McBride OW, Saffiotti U and Gajdusek DC (1987) Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer’s disease. Science 235:877–880

    Article  PubMed  CAS  Google Scholar 

  • Henriksson T, Barbour RM, Braa S, Ward P, Fritz LC, Johnson-Wood K, Chung HD, Burke W, Reinikainen KJ, Riekkinen P and Schenk DB (1991) Analysis and quantitation of the beta-amyloid precursor protein in the cerebrospinal fluid of Alzheimer’s disease patients with a monoclonal antibody-base immunoassay. J Neurochem 56:1037–1042

    Article  PubMed  CAS  Google Scholar 

  • Ishiura S (1991) Proteolytic cleavage of the Alzheimer’s disease amyloid A4 precursor protein. J Neurochem 56:363–369

    Article  PubMed  CAS  Google Scholar 

  • Kanfer JN and McCartney DG (1989) Glycerophosphorylcholine phosphodiesterase activity of rat brain myelin. J Neurosci Res 24:231–240

    Article  PubMed  CAS  Google Scholar 

  • Kang J, Lemaire H-G, Unterbeck A, Salbaum JM, Masters CL, Grzeschik K-H, Multhaup G, Beyreuther K and Mueller-Hill B (1987) The precursor of Alzheimer’s disease amyloid A4 protein resembles a cell surface receptor. Nature 325:733–736

    Article  PubMed  CAS  Google Scholar 

  • Kitaguchi N, Takahashi Y, Tokushima Y, Shiojiri S and Ito H (1988) Novel precursor of Alzheimer’s disease amyloid protein shows protease inhibitory activity. Nature 331:530–532

    Article  PubMed  CAS  Google Scholar 

  • Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL and Beyreuther K (1985) Amyloid plaque core protein in Alzheimer’s disease and Down’s syndrome. Proc Natl Acad Sci USA 82:4245–4249

    Article  PubMed  CAS  Google Scholar 

  • Miatto O, Gonzalez G, Buonanno F and Growdon JH (1986) In vitro 31P NMR spectroscopy detects altered phospholipid metabolism in Alzheimer’s disease. Can J Neurol Sci 13:535–539

    PubMed  CAS  Google Scholar 

  • Nishizuka Y (1986) Studies and perspectives of protein kinase C. Science 233:305–312

    Article  PubMed  CAS  Google Scholar 

  • Nitsch RM, Blusztajn JK, Pittas AG, Slack BE, Growdon JH and Wurtman RJ (1992) Evidence for a membrane defect in Alzheimer’s disease brain. Proc Natl Acad Sci USA 89:1671–1675

    Article  PubMed  CAS  Google Scholar 

  • Olson MI and Shaw C-M (1969) Presenile dementia and Alzheimer’s disease in mongolism. Brain 92:147–156

    Article  PubMed  CAS  Google Scholar 

  • Oltersdorf T, Ward PJ, Henricksson T, Beattie EC, Neve R, Lieberburg I and Fritz LC (1990) The Alzheimer amyloid precursor protein. J Biol Chem 265:4492–4497

    PubMed  CAS  Google Scholar 

  • Palmert MA, Berman Podlisny M, Witker DS, Oltersdorf T, Younkin LH, Selkoe DJ and Younkin SG (1989) The beta-amyloid protein precursor of Alzheimer’s disease has soluble derivatives found in human brain and cerebrospinal fluid. Proc Natl Acad Sci USA 86:6338–6342

    Article  PubMed  CAS  Google Scholar 

  • Pettegrew JW, Panchalingam K, Moosy J, Martinez J, Rao G and Boiler F (1988) Correlation of phosphorus-31 magnetic resonance spectroscopy and morphologic findings in Alzheimer’s disease. Arch Neurol 45:1093–1096

    Article  PubMed  CAS  Google Scholar 

  • Pettegrew JW, Kopp SJ, Minshew NJ, Glonek T, Feliksik JM, Tow JP and Cohen MM (1987) 31P nuclear magnetic resonance studies of phosphoglyceride metabolism in developing and degenerating brain: Preliminary observations. J Neuropathol Exp Neurol 46:419–430

    Article  PubMed  CAS  Google Scholar 

  • Podlisny MB, Lee G and Selkoe DJ (1987) Gene dosage of the amyloid-beta precursor protein in Alzheimer’s disease. Science 238:669–671

    Article  PubMed  CAS  Google Scholar 

  • Prior R, Moenning U, Schreiter-Gasser U, Weidemann A, Blennow K, Gottfries CG, Masters CL and Beyreuther K (1991) Quantitative changes in the amyloid beta/A4 precursor protein in Alzheimer cerebrospinal fluid. Neurosci Lett 124:69–73

    Article  PubMed  CAS  Google Scholar 

  • St. George-Hyslop PH, Tanzi RE, Polinsky RJ, Neve RL, Pollen D (1987) absence of duplication of chromosome 21 genes in familial and sporadic Alzheimer’s disease. Science 235:885–889

    Article  Google Scholar 

  • Selkoe D (1990) Deciphering Alzheimer’s disease: The amyloid precursor protein yields clues. Science 248:1058–1060

    Article  PubMed  CAS  Google Scholar 

  • Sisodia SS, Koo EH, Beyreuther K, Unterbeck A, Price DL (1990) Evidence that beta-amyloid protein in Alzheimer’s disease in not derived by normal processing. Science 248:492–495

    Article  PubMed  CAS  Google Scholar 

  • Stokes CE, Hawthorne JN (1987) Reduced phosphoinositide concentrations in anterior temporal cortex of Alzheimer-diseased brains. J Neurochem 48:1018–1021

    Article  PubMed  CAS  Google Scholar 

  • Ponte P, Gonzalez-DeWhitt P, Schilling J, Miller J, Hsu D, Greenberg B, Davis K, Wallace W, Lieberburg I, Fuller F, Cordell B (1988) A new A4 amyloid mRNA contains a domain homologous to serine protease inhibitors. Nature 331:525–527

    Article  PubMed  CAS  Google Scholar 

  • Tanzi RE, Bird ED, Latt SA, Neve RL (1987) The amyloid beta protein gene is not duplicated in brains from patients with Alzheimer’s disease. Science 238:666–669

    Article  PubMed  CAS  Google Scholar 

  • Tanzi RE, McClatchey AI, Lamperti ED, Villa-Komaroff L, Gusella JF, Neve RL (1988) Protease inhibitor domain encoded by an amyloid protein precursor mRNA assaciated with Alzheimer’s disease. Nature 331:528–530

    Article  PubMed  CAS  Google Scholar 

  • Terry RD, Peck A, DeTeresa R, Schechter R, Horoupian DS (1981) Some morphometric aspects of the brain in senile dementia of the Alzheimer type. Ann Neurol 10:184–192

    Article  PubMed  CAS  Google Scholar 

  • Wang R, Meschia JF, Cotter RJ, Sisodia SS (1991) Secretion of the beta/A4 amyloid precursor protein. Identification of a cleavage site in cultured mammalian cells. J Biol Chem 266:16960–16964

    PubMed  CAS  Google Scholar 

  • Weidemann A, Koenig G, Bunke D, Fischer P, Salbaum JM, Masters CL and Beyreuther K (1989) Identification, biogenesis, and localization of precursors of Alzheimer’s disease A4 amyloid protein. Cell 57:115–126.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Nitsch, R.M., Slack, B.E., Growdon, J.H., Wurtman, R.J. (1993). Accelerated Cell Membrane Degradation in Alzheimer’s Disease Brain: Relationship to Amyloid Formation?. In: Massarelli, R., Horrocks, L.A., Kanfer, J.N., Löffelholz, K. (eds) Phospholipids and Signal Transmission. Nato ASI Series, vol 70. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-02922-0_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-02922-0_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-02924-4

  • Online ISBN: 978-3-662-02922-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics